Sarepta Therapeutics, Inc. (LON:0L35)
London · Delayed Price · Currency is GBP · Price in USD 23.56
-0.76 (-3.13%)
At close: Nov 3, 2025
Sarepta Therapeutics Market Cap
Sarepta Therapeutics has a market cap or net worth of 1.82 billion as of November 3, 2025. Its market cap has decreased by -80.05% in one year.
Market Cap
1.82B
Enterprise Value
2.25B
Revenue
1.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
23.56
Market Cap Chart
Since June 4, 1997, Sarepta Therapeutics's market cap has increased from 43.06M to 1.82B, an increase of 4,120.48%. That is a compound annual growth rate of 14.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 1.82B | -80.41% |
| Dec 31, 2024 | 9.28B | 31.00% |
| Dec 29, 2023 | 7.08B | -24.98% |
| Dec 30, 2022 | 9.44B | 63.02% |
| Dec 31, 2021 | 5.79B | -41.23% |
| Dec 31, 2020 | 9.85B | 35.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| GSK plc | 71.55B |
| Haleon | 31.54B |
| Smith & Nephew | 11.91B |
| ConvaTec Group | 4.85B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.65B |